invests £3m into surgical software company Cydar Medical - %

In addition to optimising in theatre decision-making, clinicians benefit from Cydar’s Surgical Intelligence system which learns from every case to develop a deeper understanding of endovascular surgery, resulting in better outcomes for patients. Andrew Wolfson, CEO of Pembroke Investment Managers LLP commented; ’When we met Tom Carrell we were hugely impressed with his desire to develop a product that resulted in better patient outcomes. We are very pleased to partner with Pembroke VCT at this exciting stage as we scale up to realise our long-term vision to improve the outcomes of image-guided surgery for everyone” Paul Mussenden, CEO said: “Since I joined Cydar in October 2020, we have restructured the business, accelerated product development and evolved our go to market strategy by securing a range of commercial partnerships, such as that announced with Philips, the leading OEM, in January 2022. The investment team aims to find exceptional, innovative founders to grow the brands of tomorrow – giving investors the opportunity to share in the growth of some of Britain’s most exciting and entrepreneurial smaller companies. Specialising in minimally-invasive endovascular surgery, he established the complex aortic programme at Guy’s and St Thomas’ Hospitals in London and embarked on the research partnership with Graeme Penney that led to the founding of Cydar.